from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2175c/-

LFCtreatmentdescriptionclass of inhibitor

0.400

Amikacinug/mL Amikacintranslation

-0.199

Cap5-10ug/mL Capreomycintranslation

0.542

Rox10-50 ug/mL Roxithromycintranslation

0.626

SM2-5 ug/mL Streptomycintranslation

0.462

Tet5-10 ug/mL Tetracyclinetranslation

-0.560

Rif0.2-5ug/mL Rifampicintranscription

-0.425

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.305

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.134

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.293

CPZ10-50 ug/mL Chlorpromazinerespiration

0.829

Clofazimine10-13 ug/mL Clofaziminerespiration

0.077

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.828

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.982

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.188

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.486

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.770

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.317

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.584

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.044

KCN5-20 ug/mL Potassium cyaniderespiration

-0.577

NaN30.2-2 mM Sodium aziderespiration

0.487

Nigericin50 uM Nigericinrespiration

0.559

TRC10-150 ug/mL Triclosanrespiration

1.652

TRZ10-25 ug/mL Thioridazinerespiration

-0.060

Valinomycin0.5-10 uM Valinomycinrespiration

0.109

ZnSO42 mM ZnSO4respiration

1.096

menadione6-10 ug/mL Menadionerespiration

0.742

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.303

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.157

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.580

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.497

NRP_1Non-replicating persistence stage 1dosRassociated

-0.136

Amp0.2mg/mL AmpicillincellWall

-0.037

Cephalexin20-100 ug/mL CephalexincellWall

-0.191

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.244

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.202

EMB10-20 ug/mL EthambutolcellWall

0.312

Eta12-40 ug/mL EthionamidecellWall

0.765

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.276

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.529

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.679

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.201

BZA0.12 mg/mL BenzamidearomaticAmides

-0.595

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.682

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.764

H2O24 mM hydrogen peroxideDNAdamaging

-0.271

Levo10 ug/mL LevofloxacinDNAdamaging

-0.826

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.662

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.686

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.585

UVUV-irradiationDNAdamaging

0.629

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.990

Antimycin12.5-50 ug/mL Antimycin A?

-0.647

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.302

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.306

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.864

PA8240.2-2 ug/mL PA-824?

0.332

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.360

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.132

Verapamil50 uM Verapamil?

-1.179

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.388

methoxatin10-20 ug/mL Methoxatin?